NeueHealth, Inc. Stock Price, News & Analysis

Bright Health Group (NYSE: BHG) has appointed Matt Manders as an independent director, effective March 1. Manders brings extensive healthcare experience, having previously served as president of Cigna Corporation’s Government and Solutions organization. His background includes managing Cigna's U.S. Government business segment, covering Medicare, Individual, and Medicaid services. With this appointment, Bright Health's Board will have 12 directors, of which 10 are independent, aligning with the company's focus on operational excellence and consumer-driven healthcare.

Bright Health Group (NYSE: BHG) will announce its fourth quarter financial results on March 2, 2022, before market opening. A conference call is scheduled for 8:00 AM Eastern Time, with participants advised to pre-register via provided links. The company focuses on technology-enabled, fully aligned systems of care in the consumer retail healthcare market. It operates two primary businesses: NeueHealth, which serves over 400,000 value-based patients, and Bright HealthCare, providing health plan products to over one million consumers nationwide.

Bright Health Group (NYSE: BHG) has announced an updated membership guidance for 2022, projecting to serve over 1 million health plan lives across its Commercial and Medicare segments. This increase stems from better-than-expected retention and growth in key markets such as Florida, North Carolina, and Texas. The company reaffirmed its revenue expectations at $6.3 to $6.5 billion. CEO Mike Mikan stated that this milestone positions the company to achieve operating efficiencies and long-term success.

Bright Health Group (NYSE: BHG) announced participation in the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 3:00 p.m. E.T. Company President and CEO Mike Mikan and CFO Cathy Smith will present and engage in discussions. Bright Health Group operates a technology-enabled system of care designed for the consumer retail healthcare market, offering services through its businesses NeueHealth and Bright HealthCare, which serve over 720,000 consumers nationally.

Bright Health Group (NYSE: BHG) has successfully closed its offering of Series A convertible perpetual preferred stock, raising $750 million. The offering included 750,000 shares sold to subsidiaries of Cigna and affiliates of New Enterprise Associates, signaling strong institutional support for the company's alignment model. The proceeds from this investment will likely facilitate the company's growth strategy and expand its healthcare offerings. Details of this transaction will be further elaborated in a Form 8-K filing with the SEC.

Bright Health Group (NYSE: BHG) reaffirmed its 2021 revenue outlook of $4.1 to $4.2 billion and introduced a promising 2022 forecast of $6.3 to $6.5 billion, indicating over 50% growth. The company aims to serve over 875,000 members in Bright HealthCare and around 400,000 patients in NeueHealth. The enterprise medical cost ratio is expected between 86% to 88%, while adjusted EBITDA is projected at a loss of $400 to $500 million. Bright Health Group is focused on leveraging its aligned care model to enhance consumer outcomes and operational success.

Bright Health Group (NYSE: BHG) announced a $750 million financing round to support its growth, featuring investments from Cigna Ventures and existing shareholder New Enterprise Associates. The financing will involve the purchase of convertible perpetual preferred stock with a 5.0% dividend and an initial conversion price of $4.55 per share. The investment underscores confidence in Bright's innovative healthcare model. The transaction is expected to close in January 2022 and does not require additional regulatory approvals.

Bright Health Group (NYSE: BHG) subsidiary NeueHealth is set to expand its operations significantly in 2022, projecting approximately $2 billion in revenue. This growth is fueled by new clinic openings in Florida, Texas, and North Carolina, increasing their clinic count to over 70. NeueHealth is also entering the Direct Contracting program starting January 1, 2022, enhancing its service offerings. The company emphasizes the shift from fee-for-service to value-based care as a key driver of its growth strategy.

Bright HealthCare announced a new partnership with University of Florida Health, expanding its provider network in Northeast, North Central, and Central Florida. This collaboration enhances access for Bright HealthCare members in cities like Jacksonville and Gainesville to renowned facilities including UF Health Shands Hospital and UF Health Cancer Hospital. Bright HealthCare serves over 719,000 consumers across 14 states and aims to increase its footprint in the market. The Medicare enrollment period runs from Oct. 15 to Dec. 7 for coverage starting Jan. 1, 2022.